Corporate Social Responsibility Report

Overview

The report presents Fosun Pharma's 2019 group performance across its pharmaceutical and healthcare businesses, including RMB28.585 billion of revenue and RMB3.463 billion of R&D expenditures. It reports 31,370 employees and substantial environmental performance data, including 7,576,550 GJ of total energy consumption and 73,583.6 tons of solid waste. The report also describes a CSR Management Committee, extensive responsible-business programs, GRI Standards core-option reporting, and independent assurance.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2019
Period: 1 January 2019 – 31 December 2019
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services